Illicit Drug Supply: Fentanyl and Xylazine
Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current information about fentanyl and xylazine including: drug supply information, pharmacology, clinical effects, medical impacts, harm reduction and treatment information. Considerations for rural populations will be discussed. Register now! […]
Substance Use Disorders in Late Life
Register Now Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, […]
How Adding a Clinical Pharmacist Improves Access to Addiction Care
Register here Presenters: Ben Miskle, PharmD, University of Iowa Hospitals and Clinics Alison Lynch, MD, MS, University of Iowa Hospitals and Clinics Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No […]
Nurses’ Practices with People Experiencing Opioid Use Disorder
Register Now Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This […]
Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches
Register Now Presenters: Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA […]
Three years of the COVID-19 Pandemic: What we’ve learned, and how it can make us better at treating rural patients with SUD
This presentation will explore lessons learned from the COVID-19 pandemic as they relate to rural populations with substance use disorder. Register and attend to learn more! Speaker: Sarah Jacobs, MD, […]
Treatment Considerations in the Age of Fentanyl
Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl […]
Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder
Register Now Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people […]
Initiating Buprenorphine for Patients Using Fentanyl
Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations […]
Xylazine and How it Harms People Who Use Drugs
Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review […]
Opioid Use Disorder and Social Determinants of Health
Presenters: Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social […]
Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders
Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will […]
Drug Use in Pregnancy (ASAM FAME Session 7)
Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, […]
Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators […]
Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape
Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will […]
Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations
This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss […]
A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior
This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for […]
Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective
Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: […]
Buprenorphine in the Age of Fentanyl: Discussing the New Guidance
Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]
Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door
This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each […]
Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine
Presenter: Michelle Lofwall, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now
Buprenorphine Dosing and Preparations in the Era of Fentanyl
Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register […]
Addressing the Intersection of Pain Management and Opioid Use: Integrating Care to Promote Healthy Outcomes
This hybrid full-day training summit will explore the clinical intersection of pain and opioid use. Interdisciplinary attendees will learn about evidence-based practices (pharmacological and non) for treating these complex and often co-occurring conditions. More information In-person participation is preferred, though a virtual option is also available. This Summit will focus on addressing pain and opioid […]
Ready or Not Here Come the Nitazenes
Presenter: Edwin Salsitz, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now
Women & Alcohol: What does stress have to do with it?
Join us on Wednesday, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee, PhD, Director, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present "Women & Alcohol: What does stress have to do with it?" Dr. McKee directs a translational program of research focused on treatment development for addictive disorders, with an emphasis on women […]
Evidence-Based Treatment of PTSD in Individuals with OUD, and Innovative Approaches for Increasing Access to Care in Rural Communities
This presentation will discuss effective treatment approaches for posttraumatic stress disorder (PTSD) in individuals with co-occurring opioid use disorder (OUD). It will also explore ways to increase access to evidence-based […]
The Changing World of Cannabis Consumption and Cannabis Regulation
Vermont Center on Behavior and Health Monthly Lecture Series Alan Budney, PhD, Professor of Psychology, Geisel School of Medicine at Dartmouth Dr. Budney has conducted extensive research on the development […]
Collaborative Care Model (CoCM) for Substance Use Disorders
Presenters: Anna Ratzliff, MD, PhD; Jasen Christensen, DO Webinar Description This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary […]
Overdose-related Compassion Fatigue in Rural Communities
Erin Winstanley, PhD Visiting Professor, University of Pittsburgh School of Medicine Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training […]
Treating Adolescents with Substance Use Disorder
Presenter: Marc Fishman, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]
Improving Continuity of Care for Justice-Involved Individuals: Lessons from the Field
Presenters: Ed Hayes, Assistant Superintendent at Franklin County Sheriff’s Office, Administrative Director of the FCSO OTP Rachel Katz, NP Director, Addiction Services, Friends of the Homeless (FOH), Medical Respite, CNP […]
Engaging People Not Ready to Quit in Smoking Treatment: Evidence-Based Approaches
Jessica Cook, PhD Professor, University of Wisconsin School of Medicine and Public Health Dr. Cook is a Professor at the University of Wisconsin School of Medicine and Public Health (UW-SMPH) […]
Northern New England ASAM Annual Conference
Conference Agenda Day One: 5 PM – 6:30 PM: Conference Check-in and Welcome Reception Refreshments and social hour. 6:30 PM – 7:30 PM: […]
Northern New England ASAM Annual Conference
Conference Agenda Day Two: 8:30 AM – 8:45 AM: Welcome Remarks Clifton “Fred” Lord MD, President of NNESAM, ASAM Fellow, Board Certified in Addiction Medicine, CEO/Medical Director/Chairman of the […]
An Overview of the Kentucky Women’s Justice Community Opioid Innovation Network (JCOIN)
Michele Staton, PhD Professor, University of Kentucky College of Medicine Dr. Michele Staton is a Professor in the Department of Behavioral Science, and a Faculty Associate of the Center on […]
Welcoming, Integrated Services for People with Co-Occurring Disorders: Part One
Presenter: Kenneth Minkoff, MD This presentation describes how to design systems and services based on the expectation that individuals and families will have co-occurring MH, SUD, health conditions, trauma, and […]